logo

Spectrum Pharmaceuticals Inc (SPPI)



Trade SPPI now with
  Date
  Headline
10/7/2021 9:16:58 AM Spectrum Pharmaceuticals Announces Presentation Of Poziotinib In Combination With KRASG12C Inhibitors
3/11/2021 7:06:45 AM Spectrum Gets Fast Track Designation For Poziotinib For NSCLC In Prior Treated Patients With HER2 Exon 20 Mutation
1/22/2021 7:07:01 AM Spectrum Announces Oral Presentation Efficacy, Safety Of Poziotinib From Cohorts 1 And 2 Of ZENITH20 Trial
12/14/2020 7:06:23 AM Spectrum Pharmaceuticals Appoints Nora Brennan To Board
10/26/2020 7:23:35 AM Spectrum Says FDA Is Deferring Its Action On BLA For ROLONTIS Or Eflapegrastim
9/18/2020 7:08:00 AM Spectrum Pharma Presents Results In HER2 Exon 20 Insertion Mutations From Cohort 2 Of Poziotinib ZENITH20 Clinical Trial
9/14/2020 7:19:25 AM Spectrum Pharma Announces Two Presentations For Poziotinib At ESMO Virtual Congress 2020
7/30/2020 7:29:46 AM Spectrum Pharma Says Prices Underwritten Public Offering Of 21.7 Mln Shares At $3.00/shr
6/22/2020 9:05:17 AM Spectrum Pharmaceuticals Presents Same Day Dosing Data For ROLONTIS At AACR Virtual Annual Meeting II
12/18/2017 11:59:34 AM B. Riley Initiates Spectrum Pharmaceuticals Inc (SPPI) At Buy With $26 Price Target
4/6/2017 6:14:20 AM Jefferies Is Raising Spectrum Pharmaceuticals Inc (SPPI) 2017 Estimate To -0.98 From -1.00